Infectious disease surveillance needs for the United States: lessons from Covid-19.
Lipsitch M., Bassett MT., Brownstein JS., Elliott P., Eyre D., Grabowski MK., Hay JA., Johansson MA., Kissler SM., Larremore DB., Layden JE., Lessler J., Lynfield R., MacCannell D., Madoff LC., Metcalf CJE., Meyers LA., Ofori SK., Quinn C., Bento AI., Reich NG., Riley S., Rosenfeld R., Samore MH., Sampath R., Slayton RB., Swerdlow DL., Truelove S., Varma JK., Grad YH.
The COVID-19 pandemic has highlighted the need to upgrade systems for infectious disease surveillance and forecasting and modeling of the spread of infection, both of which inform evidence-based public health guidance and policies. Here, we discuss requirements for an effective surveillance system to support decision making during a pandemic, drawing on the lessons of COVID-19 in the U.S., while looking to jurisdictions in the U.S. and beyond to learn lessons about the value of specific data types. In this report, we define the range of decisions for which surveillance data are required, the data elements needed to inform these decisions and to calibrate inputs and outputs of transmission-dynamic models, and the types of data needed to inform decisions by state, territorial, local, and tribal health authorities. We define actions needed to ensure that such data will be available and consider the contribution of such efforts to improving health equity.